Related Experiment Videos
Recovery of Cryptococcus neoformans from the nasopharynx of AIDS patients
S Sukroongreung1, B Eampokalap, S Tansuphaswadikul
1Department of Clinical Microbiology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand. mtssk@mahidol.ac.th
Abstract:
Nasopharyngeal swabbings, obtained from AIDS patients, were plated onto Niger seed agar containing antibiotics Cryptococcus neoformans was isolated from 35 out of 84 patients (41.7%) diagnosed as primary cryptococcal cases before antifungal administration, and 8 out of 86 (9.3%) cryptococcosis patients on antifungal therapy. The fungus could not be isolated from any of 447 samples from 194 AIDS patients not diagnosed with cryptococcosis. These findings are novel in that the presence of C. neoformans in AIDS patients at this site has never been looked at previously.
Insights
Cryptococcus neoformans was found in the nasopharyngeal swabs of over 40% of AIDS patients with primary cryptococcal disease. This study is the first to investigate C. neoformans in this location in AIDS patients.
Area of Science:
- Medical Mycology
- Infectious Diseases
- HIV/AIDS Research
Background:
- Cryptococcus neoformans is an opportunistic fungal pathogen that causes cryptococcosis, a serious infection particularly in individuals with compromised immune systems, such as those with Acquired Immunodeficiency Syndrome (AIDS).
- The nasopharynx is a potential reservoir for various microorganisms, but its role in cryptococcal infections, especially in the context of AIDS, has not been extensively studied.
Purpose of the Study:
- To investigate the prevalence of Cryptococcus neoformans in nasopharyngeal swabbings of patients with AIDS.
- To determine if C. neoformans can be isolated from the nasopharynx of AIDS patients with and without active cryptococcosis.
Main Methods:
- Nasopharyngeal swabs were collected from patients diagnosed with AIDS.
- Samples were cultured on Niger seed agar supplemented with antibiotics to isolate Cryptococcus neoformans.
- Patients were categorized based on their cryptococcosis diagnosis and antifungal therapy status.
Main Results:
- Cryptococcus neoformans was isolated from 35 out of 84 (41.7%) AIDS patients diagnosed with primary cryptococcal disease before antifungal treatment.
- The fungus was detected in 8 out of 86 (9.3%) AIDS patients undergoing antifungal therapy for cryptococcosis.
- No isolates of C. neoformans were obtained from 447 samples from 194 AIDS patients without a diagnosis of cryptococcosis.
Conclusions:
- The nasopharynx is a site from which Cryptococcus neoformans can be readily isolated in AIDS patients, particularly those with active or primary cryptococcal disease.
- These findings suggest the nasopharynx may serve as a reservoir or a site of colonization for C. neoformans in the immunocompromised population.
- Further research is warranted to understand the clinical significance and implications of nasopharyngeal C. neoformans detection in AIDS patients.